Loading organizations...
American Century Investments is an independent asset management firm based in Kansas City, Missouri, providing mutual funds, ETFs, and systematic investment strategies to individual and institutional clients. The organization manages approximately $230 billion in total assets under management and employs around 1,400 people across its global offices. The firm directs over 40% of its profits to its controlling owner, the Stowers Institute for Medical Research, resulting in more than $2 billion in dividend payments since 2000. The company expanded its offerings in 2019 by launching Avantis Investors, a subsidiary focused on factor-based strategies that recently surpassed $100 billion in assets. Corporate stakeholders have historically included major financial institutions, with CIBC acquiring a 41% equity stake from JP Morgan Chase in 2011. The investment firm was originally founded in 1958 by James E. Stowers Jr.
Key people at American Century Investments.
American Century Investments was founded in 1958 by James E. Stowers Jr. (Founder).
# American Century Investments: A Global Asset Manager with a Unique Mission
American Century Investments is a privately controlled, independent asset management firm that manages investments for financial professionals, institutions, corporations, and individual investors worldwide[1]. Founded with a mission to help people achieve financial independence, the firm has evolved into a leading global asset manager with approximately $300 billion in assets under supervision as of September 2025[3].
The company's defining characteristic is its ownership structure: the Stowers Institute for Medical Research holds the controlling majority stake, and the firm has directed over $2 billion in dividends to the institute since 2000 to support breakthrough biomedical research[3]. This creates a unique alignment where investment success directly funds scientific discovery, particularly in cancer research and fundamental cellular biology.
American Century's investment philosophy emphasizes long-term strategic investing with a focus on delivering superior investment performance while building enduring client relationships[4]. The firm serves a broad spectrum of clients—from individual retail investors to large institutional portfolios—through multiple investment vehicles including mutual funds, separately managed accounts, and exchange-traded funds (ETFs).
James E. Stowers Jr. founded American Century Investments in 1958 in Kansas City, Missouri, initially as "Twentieth Century Mutual Funds"[1]. Stowers launched the venture with remarkable modesty: just $100,000 in assets from 24 shareholders and three employees[2]. His founding vision was deliberately focused on small investors rather than wealthy institutions—a contrarian approach for the era.
In the 1970s, Stowers pioneered one of the first computer-driven stock screening processes, an innovation that delivered measurable outperformance and earned him recognition from Money magazine as a top stock picker[2]. The company expanded methodically through the 1980s and 1990s, adding fixed-income funds, acquiring the Benham Group, and launching international strategies.
The firm's trajectory took a profound turn in 1994 when Jim and Virginia Stowers, both cancer survivors, established the Stowers Institute for Medical Research and endowed it with much of their personal wealth[6]. This decision fundamentally shaped the company's identity: rather than pursuing traditional private equity exit strategies, American Century became structured to perpetually fund medical research through its investment success. The company changed its name to American Century Investments in 1997 to reflect its broader scope[1].
American Century operates at an inflection point in global asset management. The firm is riding three major industry trends simultaneously:
Active Management Renaissance: While passive indexing dominated the 2010s, active ETFs have emerged as a growth category where skill and differentiation matter. American Century's early positioning in this space—launching Avantis in 2019 before the category exploded—positioned it to capture significant assets[3].
Sustainable & Impact Investing: The firm's integration of ESG and sustainable strategies reflects broader institutional demand for values-aligned investing. Its unique structure—where profits fund medical research—gives it authentic credibility in impact investing conversations[5].
Institutional Consolidation & Independence: As mega-asset managers (BlackRock, Vanguard, Fidelity) dominate by scale, independent firms like American Century differentiate through specialized expertise, personalized service, and mission alignment. The firm's resistance to full acquisition despite external stakes demonstrates the value of independence[1].
American Century's influence extends beyond returns: it demonstrates that alternative ownership structures can sustain competitive advantage. By aligning investment success with medical research, the firm attracts mission-driven talent and clients seeking purpose-driven capital allocation—a growing segment.
American Century Investments has achieved a rare feat: building a $300 billion asset manager while maintaining independence and directing billions to scientific research. The firm's trajectory suggests several emerging priorities:
Expansion in Private Markets: The firm recently entered private equity, signaling intent to diversify beyond public markets and capture higher-margin institutional mandates[2].
Global Institutional Growth: With offices across major financial centers and partnerships like the Nomura relationship, American Century is positioning itself as a truly global alternative to U.S.-centric mega-managers[5].
Active ETF Dominance: As the fourth-largest active ETF issuer, the firm has momentum to capture further share in this high-growth category, particularly as institutional investors seek tax efficiency and transparency[3].
The fundamental question shaping American Century's future is whether mission-driven asset management becomes a competitive advantage or a niche positioning. If institutional investors increasingly demand impact alongside returns—and if the firm can demonstrate that its research funding creates measurable societal value—American Century could become a template for reimagining asset management's purpose. Conversely, if scale and cost efficiency remain paramount, the firm's independence and mission focus may limit its ability to compete with trillion-dollar platforms.
What makes American Century distinctive is not just its size or returns, but its proof that capitalism and scientific progress can be structurally aligned—a model that resonates increasingly with stakeholders questioning whether traditional finance serves society's deepest needs.
American Century Investments has 3 tracked investments across 2 companies. The latest tracked deal is $10.0M Other Equity in Claros Technologies in August 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 12, 2025 | Claros Technologies | $10.0M Other Equity | — | Kathleen A. Tune, F. R. Bigelow Foundation, University OF Minnesota |
| Oct 10, 2024 | Rivermark Medical | $30.0M Series C | American Century Investments | — |
| May 28, 2024 | Claros Technologies | $22.0M Other Equity | American Century Investments, Sasha Brown | Capita3, Children's Minnesota, F. R. Bigelow Foundation, Groundswell Ventures, Kureha America, Open Door Foundation, University OF Minnesota |
American Century Investments was founded in 1958 by James E. Stowers Jr. (Founder).
Key people at American Century Investments.
